Back to articles
Comparative guide · 8 min read · Safety-critical

5-HTP vs L-tryptophan vs SAMe — three serotonin-pathway supplements compared

Updated 2026-05-02 · Reviewed by SupplementScore editors · No sponsorships

All three of these are sold as mood, sleep, or stress supplements, and all three plug into different points of the same biochemistry. They're commonly mistaken for interchangeable. They aren't — and one specific drug interaction with each is potentially dangerous. Read the contraindications section before deciding.

Read this first. If you take an SSRI, SNRI, MAOI, tramadol, triptan, MDMA, or any other serotonergic medication, do not start any of these three supplements without first speaking to your prescribing clinician. The combined risk of serotonin syndrome is real and occasionally fatal. This is not a generic "talk to your doctor" disclaimer; it's the single most important point in this article.

Quick verdict

GoalBest-fit formWhy
Mild low mood, no medication overlap SAMe Strongest evidence base for depressive symptoms; multiple positive RCTs vs placebo. Expensive but the best-supported of the three.
Sleep onset (subjective) L-tryptophan Modest sleep-onset benefit at 1–2 g doses. Better safety profile than 5-HTP at supplement doses.
Appetite suppression / weight-loss claims None of these 5-HTP is marketed for this; the data are weak and short-term. Don't buy it for this reason.

Where each one acts in the pathway

Serotonin is made from the dietary amino acid tryptophan via two steps: tryptophan → 5-HTP → serotonin. SAMe doesn't sit on this pathway directly; it's a methyl donor that supports synthesis of serotonin, dopamine, and norepinephrine through methylation reactions, and it has independent effects on phospholipid metabolism in neuronal membranes.

L-tryptophan — one step upstream of 5-HTP

Crosses the blood-brain barrier in competition with other large neutral amino acids. Conversion to 5-HTP is rate-limited by tryptophan hydroxylase, which is partly why eating a high-carb meal helps tryptophan get into the brain (insulin clears competing amino acids). Sleep evidence is modest: 1 g at bedtime reduces sleep latency in controlled studies.

5-HTP — one step closer to serotonin

Bypasses the rate-limiting step. Most often sourced from Griffonia simplicifolia seeds. Faster serotonergic effect than L-tryptophan, which is what makes it more attractive — and more risky. The peripheral conversion to serotonin happens in the gut and bloodstream as well as the brain, which is part of why 5-HTP commonly causes nausea at higher doses. Often co-formulated with vitamin B6, which is required for the decarboxylase reaction.

SAMe — a parallel pathway entirely

S-adenosyl-L-methionine is a universal methyl donor. It supports synthesis of all the monoamine neurotransmitters and is central to phospholipid methylation in cell membranes. The depressive-symptoms RCT base is the strongest of the three (multiple positive trials vs placebo, some equivalence trials vs SSRIs). It's also the most expensive (typically $1–2 per day at the trial-validated 800–1600 mg dose), and stability is delicate — buy enteric-coated tablets stored cool.

Drug-interaction profile

This is the practical decider for many readers.

What about the EMS scare with L-tryptophan?

The 1989 eosinophilia-myalgia syndrome outbreak (1,500+ cases, 30+ deaths) was traced to a contaminated batch from a single Japanese manufacturer (Showa Denko), not to L-tryptophan itself. The FDA banned imports for over a decade. Pharmaceutical-grade tryptophan is now back on the US market with a clean safety record. The lesson, though, is real: always buy from a third-party-verified brand for these compounds. Cheap L-tryptophan or 5-HTP from unverified sellers is not worth the risk.

Practical decision tree. Are you on a serotonergic prescription? → don't start any of these. Otherwise: depressive symptoms → SAMe (talk to a clinician first). Sleep onset only → L-tryptophan, low dose. Considering 5-HTP? → use the lowest effective dose (50–100 mg), preferably with food, ideally only short-term, and only from a third-party-tested brand.

Who should not use any of these

Anyone on the medications above. Anyone with carcinoid syndrome (the body already over-produces serotonin). Anyone with bipolar disorder (SAMe in particular has triggered mood elevation episodes). Children and adolescents — paediatric data are insufficient for all three.